Is INSM overvalued right now?
Based on our 2026 models, Insmed Incorporated (INSM) appears overvalued at $111.54 with roughly 123.6% downside versus fair value. Confirm with valuation ratios and financials before acting.
Insmed Incorporated (INSM) is currently Overvalued by 123.60%
Instant valuation answer
Insmed Incorporated (INSM) appears overvalued by approximately 123.60% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.
- Downside (live) 123.60% (from live valuation API)
- Confidence (live) 8.5/10 (High conviction overvalued)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$111.54
Stock valuation checker
Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.
Explore Our Valuation Calculators
Why is Insmed Incorporated overvalued or undervalued?
Intrinsic value work anchors Insmed Incorporated on owner earnings and balance-sheet capacity; the current quote trades below that anchor, which frames the stock as relatively cheap on a fundamentals-first view.
Versus historical valuation bands, INSM is closer to the lower end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.
Forward market expectations are muted: the price does not require heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.
Key metrics
- P/E ratio
- 12.4x
- Revenue growth (TTM y/y)
- 11%
- Profit margin
- 11.1%
- Fair value (model)
- Unlock
Frequently asked questions — INSM
What is Insmed Incorporated's intrinsic value?
Our DCF, P/E Multiple, and P/S Multiple models estimate whether INSM trades above or below fair value. At $111.54, Insmed Incorporated currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.
How is Insmed Incorporated's intrinsic value calculated?
Tickerplace calculates INSM's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is INSM undervalued right now?
A stock is undervalued when price sits below a supportable fair value range. Check whether INSM's gap aligns with fundamentals using the ratios and financial links on this page.
Related companies — valuation
Peers for INSM: open their overvalued / undervalued view.